{"id":1508,"date":"2021-07-27T08:17:38","date_gmt":"2021-07-27T12:17:38","guid":{"rendered":"https:\/\/covidqanda.org\/?p=1508"},"modified":"2021-07-27T08:17:38","modified_gmt":"2021-07-27T12:17:38","slug":"will-we-need-booster-shots-soon","status":"publish","type":"post","link":"https:\/\/covidqanda.org\/?p=1508","title":{"rendered":"Will we need booster shots soon?"},"content":{"rendered":"\n<p class=\"wp-block-paragraph\"><strong><span style=\"text-decoration: underline;\">Question:<\/span><\/strong>\u00a0What does the new data from Israel mean for booster shots?\u00a0 Will we need booster shots soon?<\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><strong><span style=\"text-decoration: underline;\">Answer:<\/span><\/strong>\u00a0We still don&#8217;t know if\/when we would need booster shots and\/or if only certain subsets of the population would need booster shots.\u00a0 We&#8217;ll know more with more time and research.  I am aware of at least 3 pieces of new research published within the last week, which shed some light:<\/p>\n\n\n\n<ol class=\"wp-block-list\"><li><strong>New<a href=\"https:\/\/www.gov.il\/BlobFolder\/reports\/vaccine-efficacy-safety-follow-up-committee\/he\/files_publications_corona_two-dose-vaccination-data.pdf\"> data from Israel <\/a>show Pfizer&#8217;s effectiveness against infection is potentially waning:<\/strong> Israel, having achieved&nbsp;one of the world&#8217;s highest vaccination coverage rates, has been closely studying vaccine effectiveness in the general population.&nbsp; A few days ago, the government released preliminary data on vaccine effectiveness over time, which indicated that effectiveness may have waned <strong>(Figure 1<\/strong>).&nbsp; This could be due to a number of factors, including: a) small sample size limiting ability to extrapolate to broader population (e.g. the data are not robust enough to draw conclusions); b) Reduced vaccine effectiveness in response to the Delta variant; c) Diminished vaccine effectiveness over time; d) Reduction in use of other public health interventions.&nbsp; I wouldn&#8217;t put too much weight on these data due to the small&nbsp;sample size and need for more nuanced&nbsp;analysis.&nbsp; And if you&#8217;re feeling disheartened, please note that the data are very positive when it comes to Pfizer&#8217;s continued, steadfast ability to prevent severe disease outcomes (like hospitalization or death) <strong>(Figure 2<\/strong>).&nbsp; &nbsp;<\/li><li><strong>New <a href=\"https:\/\/assets.publishing.service.gov.uk\/government\/uploads\/system\/uploads\/attachment_data\/file\/1005517\/Technical_Briefing_19.pdf\">data from Public Health England<\/a>&nbsp;show that the risk of reinfection is higher in association with the Delta variant: <\/strong>Public Health England recently examined the risk of reinfection between Alpha and Delta variants, running an analysis that accounted for a number of background characteristics.&nbsp; During the 11-week study period, there were 83,197 people who tested positive, of whom 980 (1.2%) were possible reinfections (e.g. had a previous positive test result 90+ days earlier). Researchers found that the odds of reinfection with the Delta variant were &#8220;1.46 (95% CI 1.03 to 2.05) compared to the Alpha variant. The risk of reinfection was not elevated for Delta if the primary infection was &lt;180 days (adjusted odds ratio = 0.79, 95% CI 0.49 to1.28) but was higher for those with a prior infection \u2265180 days earlier (adjusted odds ratio = 2.37, 95%CI 1.43 to 3.93).&#8221;&nbsp; If natural immunity wanes over time, then this could have implications for vaccine-derived immunity too (but even that is quite a&nbsp;logic leap).&nbsp; Again, we just don&#8217;t know enough yet to actually know!<\/li><li><strong>New research <a href=\"https:\/\/jamanetwork.com\/journals\/jama\/fullarticle\/2782538\">published in <em>JAMA<\/em><\/a>&nbsp;indicates a 3rd dose could be warranted for immuno-compromised individuals. <\/strong>Researchers examined the antibody responses of kidney transplant recipients who did not respond to 2 doses and received a third dose of Moderna.&nbsp; They found that the 3rd dose induced an immune response in 49% of kidney transplant recipients who had not responded after 2 doses, indicating that a 3rd dose may be beneficial for organ transplant recipients (and if one were to extrapolate, a 3rd dose would&nbsp;perhaps be beneficial to other immuno-compromised individuals as well).&nbsp;<\/li><\/ol>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Figure 1. Breakthrough Rate by Age, Month of Vaccination <\/strong>(from <a href=\"https:\/\/www.gov.il\/BlobFolder\/reports\/vaccine-efficacy-safety-follow-up-committee\/he\/files_publications_corona_two-dose-vaccination-data.pdf\">Israel<\/a>)<\/p>\n\n\n\n<figure class=\"wp-block-image size-large\"><img data-recalc-dims=\"1\" loading=\"lazy\" decoding=\"async\" width=\"723\" height=\"431\" src=\"https:\/\/i0.wp.com\/covidqanda.org\/wp-content\/uploads\/2021\/07\/image-7.png?resize=723%2C431&#038;ssl=1\" alt=\"\" class=\"wp-image-1509\" srcset=\"https:\/\/i0.wp.com\/covidqanda.org\/wp-content\/uploads\/2021\/07\/image-7.png?resize=1024%2C611&amp;ssl=1 1024w, https:\/\/i0.wp.com\/covidqanda.org\/wp-content\/uploads\/2021\/07\/image-7.png?resize=300%2C179&amp;ssl=1 300w, https:\/\/i0.wp.com\/covidqanda.org\/wp-content\/uploads\/2021\/07\/image-7.png?resize=768%2C459&amp;ssl=1 768w, https:\/\/i0.wp.com\/covidqanda.org\/wp-content\/uploads\/2021\/07\/image-7.png?w=1206&amp;ssl=1 1206w\" sizes=\"auto, (max-width: 723px) 100vw, 723px\" \/><\/figure>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Figure 2. Vaccine Effectiveness by Outcome, Month of Vaccination<\/strong>(from\u00a0<a href=\"https:\/\/www.gov.il\/BlobFolder\/reports\/vaccine-efficacy-safety-follow-up-committee\/he\/files_publications_corona_two-dose-vaccination-data.pdf\">Israel<\/a>)<\/p>\n\n\n\n<figure class=\"wp-block-image size-large\"><img data-recalc-dims=\"1\" loading=\"lazy\" decoding=\"async\" width=\"723\" height=\"503\" src=\"https:\/\/i0.wp.com\/covidqanda.org\/wp-content\/uploads\/2021\/07\/image-8.png?resize=723%2C503&#038;ssl=1\" alt=\"\" class=\"wp-image-1510\" srcset=\"https:\/\/i0.wp.com\/covidqanda.org\/wp-content\/uploads\/2021\/07\/image-8.png?resize=1024%2C712&amp;ssl=1 1024w, https:\/\/i0.wp.com\/covidqanda.org\/wp-content\/uploads\/2021\/07\/image-8.png?resize=300%2C208&amp;ssl=1 300w, https:\/\/i0.wp.com\/covidqanda.org\/wp-content\/uploads\/2021\/07\/image-8.png?resize=768%2C534&amp;ssl=1 768w, https:\/\/i0.wp.com\/covidqanda.org\/wp-content\/uploads\/2021\/07\/image-8.png?w=1036&amp;ssl=1 1036w\" sizes=\"auto, (max-width: 723px) 100vw, 723px\" \/><\/figure>\n","protected":false},"excerpt":{"rendered":"<p>Question:\u00a0What does the new data from Israel mean for booster shots?\u00a0 Will we need booster shots soon? Answer:\u00a0We still don&#8217;t know if\/when we would need booster shots and\/or if only certain subsets of the population would need booster shots.\u00a0 We&#8217;ll know more with more time and research. I am aware of at least 3 pieces [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":1510,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"nf_dc_page":"","om_disable_all_campaigns":false,"_monsterinsights_skip_tracking":false,"_jetpack_newsletter_access":"","_jetpack_dont_email_post_to_subs":false,"_jetpack_newsletter_tier_id":0,"_jetpack_memberships_contains_paywalled_content":false,"_jetpack_feature_clip_id":0,"_jetpack_memberships_contains_paid_content":false,"footnotes":"","jetpack_post_was_ever_published":false},"categories":[40,38,17,46,64],"tags":[209,184,173,65],"class_list":["post-1508","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-disease-severity","category-immunity","category-risk-reduction","category-trends","category-vaccines","tag-delta","tag-immunocompromised","tag-israel","tag-reinfection","fallback-thumbnail"],"jetpack_sharing_enabled":true,"jetpack_featured_media_url":"https:\/\/i0.wp.com\/covidqanda.org\/wp-content\/uploads\/2021\/07\/image-8.png?fit=1036%2C720&ssl=1","_links":{"self":[{"href":"https:\/\/covidqanda.org\/index.php?rest_route=\/wp\/v2\/posts\/1508","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/covidqanda.org\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/covidqanda.org\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/covidqanda.org\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/covidqanda.org\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=1508"}],"version-history":[{"count":1,"href":"https:\/\/covidqanda.org\/index.php?rest_route=\/wp\/v2\/posts\/1508\/revisions"}],"predecessor-version":[{"id":1511,"href":"https:\/\/covidqanda.org\/index.php?rest_route=\/wp\/v2\/posts\/1508\/revisions\/1511"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/covidqanda.org\/index.php?rest_route=\/wp\/v2\/media\/1510"}],"wp:attachment":[{"href":"https:\/\/covidqanda.org\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=1508"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/covidqanda.org\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=1508"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/covidqanda.org\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=1508"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}